Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study
Hormone Research, 10/27/09
Romer T et al. – The clinical comparability between Omnitrope and Genotropin was demonstrated within 9 months of treatment. Long–term safety and efficacy of 7 years of treatment with Omnitrope was proven.
Today in Metabolism and Growth...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting the Response to Growth Hormone Treatment in Short Children with Chronic Kidney Disease
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Autoimmune polyglandular syndrome Type 3 and growth hormone deficiency
Pediatric Diabetes, 12/15/09
High-Calorie Glucose-Rich Food Attenuates Neuroglycopenic Symptoms in Patients with Addison's Disease
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Today in Pediatric Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting the Response to Growth Hormone Treatment in Short Children with Chronic Kidney Disease
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/17/09
Pediatric Endocrinologists Management of Children, With Type 2 Diabetes Mellitus
Diabetes Care, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


